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The ectopic expression of transcription factors can
reprogram cell fate, yet it is unknown how the initial
binding of factors to the genome relates functionally
to the binding seen in the minority of cells that
become reprogrammed. We report a map of Oct4,
Sox2, Klf4, and c-Myc (O, S, K, and M) on the human
genomeduring the first 48 hr of reprogramming fibro-
blasts to pluripotency. Three striking aspects of the
initial chromatin binding events include an unex-
pected role for c-Myc in facilitating OSK chromatin
engagement, the primacy of O, S, and K as pioneer
factors at enhancers of genes that promote reprog-
ramming, and megabase-scale chromatin domains
spanned by H3K9me3, including many genes re-
quired for pluripotency, that prevent initial OSKM
binding and impede the efficiency of reprogramming.
We find diverse aspects of initial factor binding that
must be overcome in the minority of cells that
become reprogrammed.INTRODUCTION
Cellular reprogramming by transcription factors is remarkable for
its potential to impact research and therapies, yet it remains
inefficient in practice (Graf and Enver, 2009). One of the most
striking examples is the ability of the transcription factors Oct4,
Sox2, Klf4, and c-Myc (O, S, K, and M) to reprogram somatic
cells to become induced pluripotent stem (iPS) cells (Takahashi
and Yamanaka, 2006). Yet only a minority of cells in which the
reprogramming factors are expressed will productively convert
(Plath and Lowry, 2011). Little is known about the mechanisms
by which reprogramming factors initially interact with the
genome, how the initial binding network compares to that in later
stages, and the chromatin structures that may guide or impede
factor binding. By investigating the initial events in factor binding,
we sought to shed light onmechanisms thatmay promote or limit
reprogramming.
During embryonic development, a subset of transcription
factors known as ‘‘pioneer factors’’ initially access silent994 Cell 151, 994–1004, November 21, 2012 ª2012 Elsevier Inc.chromatin and direct the binding of other transcription factors
(Cirillo et al., 2002; Zaret and Carroll, 2011). Other transcription
factors can access their chromatin target sites cooperatively
(Adams and Workman, 1995; Filion et al., 2010). Reprogram-
ming to pluripotency is stepwise, with morphological changes
and apoptosis occurring in the first 48 hr (Samavarchi-Tehrani
et al., 2010; Smith et al., 2010), changes in H3K4me2 modi-
fication occurring by one cell division (48 hr) (Koche et al.,
2011), and transcriptional changes occurring at genes whose
promoters were marked by H3K4me3 (Koche et al., 2011;
Mah et al., 2011). Early steps involve a mesenchymal-
to-epithelial transition (MET) via silencing of Snail genes,
suppression of TGF-b signaling, and upregulating E-cadherin
(CDH1) (Li et al., 2010; Mah et al., 2011). The P53 pathway
promotes apoptosis and senescence, and its suppression
enhances reprogramming (Hong et al., 2009; Kawamura
et al., 2009; Mario´n et al., 2009). The timing and extent to which
these genes and pathways are first targeted during reprogram-
ming are unknown.
Genome-wide occupancy maps of embryonic stem (ES) and
iPS cells have revealed that the OSK factors are central to the
core pluripotency network, whereas c-Myc, bound to promoters,
is part of a distinct network (Boyer et al., 2005; Chen et al., 2008;
Kim et al., 2008; Sridharan et al., 2009). Mouse fibroblasts at
a late stage of reprogramming (pre-iPS) contained c-Myc at
promoters similar to that seen in iPS and ES cells (Sridharan
et al., 2009). c-Myc can be replaced by Glis1 during reprogram-
ming (Maekawa et al., 2011) or omitted, yet when combined
with OSK, c-Myc greatly improves the efficiency and kinetics
of the process (Nakagawa et al., 2008; Wernig et al., 2008).
By promoting cell growth and survival, c-Myc is thought to
indirectly enhance reprogramming by allowing more chances
for stochastic events to occur (Hanna et al., 2009; Knoepfler,
2008). Whether c-Myc plays a direct role in global chromatin
engagement is unclear.
Here, we show that the O, S, K, and M factors initially occupy
the genome in human fibroblasts in a markedly different way
compared to that in pre-iPS, iPS, and ES cells. The factors
bind together to distal elements of many genes required for
reprogramming, and there is minimal detectable effect of pre-
existing histone modifications and DNaseI hypersensitivity in
guiding most of the initial OSKM binding. We reveal a pioneer
activity of Oct4, Sox2, and Klf4 in binding closed chromatin
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Figure 1. Extensive OSKM Engagement with the Genome at 48 hr
Postinduction
(A) O, S, K, and M peak profiles showing average read counts, which are input
subtracted, lane-normalized, and as reads per million mapped reads. Read
counts within peak regions (red brackets) are compared to 1 kb flanking
regions. See Figures S1 and S2 and Table S1 for ChIP-seq details and peak
examples.
(B) De novo sequence motifs overrepresented in the O, S, K, and M peaks
compared to their canonical motifs found in the JASPAR database (Bryne
et al., 2008).
(C) Hierarchical clustering of O, S, K, and/or M cobound target genes in 48 hr
(left) and in ES cells (right). Genes are called OSKM targets if they are bound
within the gene body or 20 kb upstream and are shown as red rectangles, and
nontargets are shown as black rectangles. The genes cotargeted by all OSKM
factors are indicated in the yellow boxed region, ‘‘OSKM.’’
(D) OSKM cobound regions at 48 hr with peak distances %100 bp are more
frequent compared to those found in human ES (blue bars) (Lister et al., 2009)
and mouse ES (red bars) (Chen et al., 2008). The O, S, K, and/or M cobound
regions are expressed as ratio of that seen at 48 hr to that seen in ES cells.
Boxed area indicates extensive cobinding of c-Myc with O, S, and/or K.
See also Figures S1 and S3 and Table S3.and a direct role for c-Myc in enhancing the binding of OSK to
chromatin. We also discovered megabase-sized domains of
the genome that are refractory to OSKM binding; most of these
differentially bound regions (OSKM-DBRs) will become bound in
the minority of cells that become pluripotent. H3K9me3 is the
dominant chromatin feature at the DBRs, and knockdown of
relevantmethyltransferases allows OSKMbinding and enhances
reprogramming. Together, these studies reveal that progression
to pluripotency requires reorganization of the initial network for
c-Myc, a shift to promoter binding by OSKM, and overcoming
broad heterochromatic features that occur in the somatic cell
genome.
RESULTS
Extensive OSKM Binding to Chromatin in the First 48 hr
of Reprogramming
To investigate the initial engagement of O, S, K, andMwith chro-
matin, we transcriptionally induced the factors together in human
fibroblasts (hFib) using doxycyline (dox)-inducible lentiviral
transduction (Brambrink et al., 2008) (Figure S1A available
online). Cells were transferred to human ES (hES) culture condi-
tions on the third day and gave rise to stable hFib-iPS lines that
were maintained without dox for ten passages; these expressed
endogenous pluripotency marker proteins similar to the H1-hES
control line (Figure S1B). As expected, the hFib-iPS cells can
form embryoid bodies and differentiate into derivatives of the
three germ layers (Figure S1C). TheOSKM-infected human fibro-
blasts were reprogrammed at an efficiency of 0.05% (Fig-
ure S1D), as seen by others (Hockemeyer et al., 2008; Takahashi
et al., 2007).
We used chromatin immunoprecipitation sequencing (ChIP-
seq) to map the initial protein-DNA interactions of O, S, K, and
M with the genome. A 48 hr dox induction point was chosen
because it was the earliest for maximal OSKM expression
(data not shown), it preceded major transcriptional changes
(Koche et al., 2011; Mah et al., 2011), and it preceded the time
when the fibroblasts are changed to ES growth conditions. As
a control, we probed noninfected fibroblasts that were treated
with dox for 48 hr (Figures S1E and S1F). The DNA from eight
ChIPs for each factor from infected cells, four ChIPs from nonin-
fected control cells, and input DNAwere sequenced. We applied
model-based analysis for ChIP-seq (MACS) (Zhang et al., 2008)
to identify bound regions containing unique-mapped reads from
ChIP DNA over the input DNA and subtracted peaks from the
control ChIP reactions from uninfected cells (Figure S2A and
Table S1). Using qPCR, we validated all 65 of selected O, S,
K, and/or M peaks that were false discovery rate (FDR)
controlled to 0.005 and confirmed poor or lack of enrichment
in all of 30 regions that were distal to selected peaks (Figures
S2B and Table S2). Our analysis identified 58,174, 64,534,
61,075, and 43,968 enriched peaks for O, S, K, and M, respec-
tively, at 48 hr with an average peak width of 280 bp (Fig-
ure 1A). De novo motif discovery (Machanick and Bailey, 2011)
showed that O, S, and K are able to access many of their
specific DNA targets in early reprogramming, with M accessing
a sequence related to its canonical target (p < 1 3 105)
(Figure 1B).Clustering of OSKM Binding Is a Distinct Feature of the
Initial Reprogramming Network
Genes bound by OSKM at 48 hr were compared to ChIP-seq
data fromES cells (Chen et al., 2008) (Table S3). By unsupervised
hierarchical clustering, the initial regulatory network is exten-
sively shared between the four factors, unlike that in ES cells
(Figure 1C, red overlapping regions). Genes cotargeted by
O, S, K, and M represent 35% (11,702 out of 35,096) of all
genes bound by the factors, whereas O, S, K, and M were onlyCell 151, 994–1004, November 21, 2012 ª2012 Elsevier Inc. 995
Figure 2. OSKM Initially Targets Genes for Reprogramming and
Apoptosis
(A) Heatmap analysis showing the correlation between O, S, K, and/or M
binding in 48 hr and in ES cells and gene expression in uninfected human
fibroblasts and ES cells (Chen et al., 2008; Lowry et al., 2008; Sridharan et al.,
2009). Genes were rank ordered according to their level of expression in
fibroblast cells (cyan histogram, left) or in ES cells (red histogram, right) and
were correlated with their O, S, K, and/or M occupancy (green lines) at 48 hr
(left) or in ES cells (right), respectively. Table S3 shows expression values in
hFib, iPS, and ES cells.
(B) O, S, K, andMChIP-seq profiles (blue, red, orange, and green, respectively)
at genes bound at 48 hr and important for reprogramming or apoptosis. OSKM
peaks presented are normalized against input DNA sequenced tags. Black
triangles indicate regions validated by ChIP-qPCR, as shown in Figure S3C.
(C) O, S, K, andMbindingwith respect to TSS are displayed with the frequency
of total binding for Oct4 (blue), Sox2 (red), Klf4 (orange), and c-Myc (green) in
48 hr (left) and in ES (right, from Chen et al., 2008). See Figure S4 for detailed
O, S, K, and/or M binding combination distributions and functional enhancer
binding.
(D) Gene expression levels in fibroblasts are rank ordered from low to high (top
cyan histogram). Genes that change expression 2-fold ormore over fibroblasts
during 24, 48, 72, and >72 hr of reprogramming (Koche et al., 2011) are
displayed as yellow lines and are correlated with genes occupied by O, S, K,
and/or M in their promoters (±1 kb of TSS) at 48 hr (green lines).
See also Figures S2, S3, and S4.cobound to 3% (463 out of 15,062) of genes in ES cells (Fig-
ure 1C, yellow boxed region). At an FDR value of 0.005, our
data have more peaks (188,595) than that of Chen et al. (2008)
(19,208 at an FDR of 0.05), but the data sets have the same
magnitude of expected error (940 versus 960, respectively).
The higher number of peaks in our data set could reflect current
ChIP-seq methods and the induced level of OSKM expression,
which is typical in the field, resulting in the standard efficiency
of cellular conversion.
To gain a more mechanistic view of O, S, K, and/or M interac-
tions with DNA at the nucleosome level at 48 hr, we identified
binding peak centers that were nomore than 100 bp apart; these
overlapped by an average of 207 bp (Figure 1D, inset). We used
the same method to analyze O, S, K, and M ChIP-seq data sets
from human and mouse ES cells (Chen et al., 2008; Lister et al.,
2009). Strikingly, we found that O, S, and K sites that were
cobound with c-Myc were more frequent at 48 hr with respect
to those seen in ES cells (Figure 1D, red box). The DNA
sequences of more than half (56%) of the OSKM cobound
regions are conserved in mouse (p < 0.0001), reflecting possible
cis-regulatory function (Figures S3A and S3B). Overall, the
OSKM factors bind together at conserved, closely spaced
regions far more extensively during the initiation of reprogram-
ming than in the partially reprogrammed and fully pluripotent
states.
Using microarray expression data sets of human fibroblasts
and ES cells (Lowry et al., 2008; Maherali et al., 2008), we found
that silent genes were extensively targeted by the O, S, K, and M
factors at 48 hr, which is in contrast to that seen in ES cells (Chen
et al., 2008; Sridharan et al., 2009), in which c-Myc and Klf4 were
predominantly associatedwith active genes (Figure 2A, compare
green bars at 48 hr with those in ES cells). About 90% of genes
that change expression 2-fold or more between Fib and iPS
(7,740 out of 8,587 transcripts) or ES (9,976 out of 11,216
transcripts) are targeted by O, S, K, and/or M at 48 hr, indicat-
ing that the initial bound genes will respond transcriptionally
(Table S3).
The Initial OSKM Regulatory Network Promotes
Reprogramming and Apoptosis
OSKM bind together at genes that promote reprogramming,
including GLIS1 (Maekawa et al., 2011), the mir-302/367 cluster
(Anokye-Danso et al., 2011), and genes for MET such as SNAI2
(Figures 2B and S3C). Gene ontology analysis of O, S, K, and M
cotargets revealed that proreprogramming pathways, including
MET, are overrepresented at 48 hr (p < 1.5 3 107; Figure S3D).
Klf4 targets CDH1 at multiple sites at 48 hr (Figures 2B and S3C),
which is in concordance with ectopic Klf4, but not OSM, potently
inducing CDH1 (Li et al., 2010). The factors did not target
NANOG and DPPA4, which are activated late in reprogramming
(Tables S2 and S3) (Mikkelsen et al., 2008; Samavarchi-Tehrani
et al., 2010; Sridharan et al., 2009).
Apoptotic genes were bound extensively by OSKM at 48 hr
(GO targets p < 2.8 3 104; Figure S3D), including TP53 being
bound by all four factors and p19 (CDKN2D) being bound by
c-Myc (Figures 2B, S3C, and S3D). These findings are consistent
with c-Myc alone or OSK inducing P53 and c-Myc alone, but not
OSK, inducing p19 (Kawamura et al., 2009). We conclude that996 Cell 151, 994–1004, November 21, 2012 ª2012 Elsevier Inc.OSKM together initially bind genes that are important for early
stages of reprogramming as well as for apoptosis, with binding
to the latter explaining how the cell death pathway is rapidly acti-
vated in reprogramming experiments.
OSKM Predominantly Bind to Distal Elements in Early
Reprogramming
Using Genomic Regions Enrichment of Annotations Tool
(GREAT) (McLean et al., 2010) to determine the distribution of
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Figure 3. OSK Act as Pioneer Factors for
c-Myc, and c-Myc Enhances OSK Binding
to Chromatin
(A) Noninfected and c-Myc, OSK, or OSKM-
infected fibroblasts at 0 hr, 48 hr, and day 20 post-
induction with dox. Viability is indicated at 0 and
48 hr postinduction with dox and shows marked
apoptosis when c-Myc is expressed with OSK.
(B) ChIP-qPCR assays at 48 hr on eight OSKM
target sites (NAA35, GINS1, JMJD2C, Jmjd1A,
SMARCAD1, SOX21, LGR4, and MIR-367; Fig-
ure S5B) and eight OSK target sites (PAX6-1,
PAX6-2, PDE4D, GMPR, BckdhB, DDH2D,
ASTN2, and KCNIP2; Figure S5B). Bars indicate
means ±SEM of two biological replicates; each
qPCR reaction with three technical replicates.
(C) As for (B).
(D) The enrichment of E-box, a de novo c-Myc (see
Figure 1B), Oct4, Sox2, and Klf4 motifs within the
OSK (gray bars) versus OSKM (black bars) are
plotted against frequency of sites containing the
motifs, allowing no more than one bp mismatch.
The threshold enrichment for eachmotif in random
genomic sequences is displayed as a dotted line.
The data indicate that c-Myc is driven to OSKM
sites in part by the variant motif, ***p < 0.0001.
See also Figure S5.O, S, K, and/or M-bound sites with respect to transcription start
sites (TSS) of Refseq genes, we found that the factors bind distal
to promoters at 48 hr of induction (Figure 2C). Apart from Klf4
and c-Myc cobound regions, which showed a tendency to
bind promoters, all the other O, S, K, and/or M combinations
were primarily bound to distal elements at sites that were
generally conserved between human and mouse (Figure S4A,
compare magenta line to other lines). In contrast, c-Myc binds
almost exclusively to promoters in ES cells (Figure 2C) (Chen
et al., 2008; Kim et al., 2008; Sridharan et al., 2009). Most of
the O, S, K, and/or M cobound combinations shift from being
predominantly distal to the TSS at 48 hr to being close to the
TSS in ES cells, apart from Sox2-bound sites, which remain
distal (Figure S4A). The functionality of early distal binding sites
was underscored by the marked binding of O, S, K, and M at
48 hr to validated enhancers (Visel et al., 2007), compared to
flanking regions of similar size (Figure S4B). Our findings support
a recent study showing that exogenous Oct4 first accesses the
enhancer and, later, the promoter of MYOD1 gene during
reprogramming (Taberlay et al., 2011). We further found that
OSKM, not just Oct4, bind three of the four enhancers of
MYOD1 and do not access the promoter at 48 hr (Figure S4C).
Our observation of the vast majority (85%) of initial OSKM
binding events occurring at distal sequences, prior to promoter
occupancy, is consistent with only a fraction of the genes
exhibiting transcriptional changes at 48 hr (Koche et al., 2011;
Mah et al., 2011), and these largely comprise the subset that
becomes bound by c-Myc and Klf4 at promoters (Figure 2D).
Thus, distal element binding is an early step in reprogramming,
preceding promoter binding and the transcriptional activation
of many target genes.Oct4, Sox2, and Klf4 Act as Pioneer Factors for c-Myc,
and c-Myc Enhances Chromatin Binding by OSK
To investigate how c-Myc cobinds so extensively with OSK after
48 hr of coexpression in fibroblasts, we separately induced the
expression of c-Myc alone, OSK, or OSKM in hFib cells. In the
context of OSK, c-Myc promoted cell death in early reprogram-
ming (Figure 3A). The OSKM-infected, but not the OSK-infected
or the c-Myc-only infected fibroblasts, formed colonies after
20 days of expression (Figure 3A). We carried out ChIP-
quantitative PCR (ChIP-qPCR) at 48 hr on eight sites from the
ChIP-seq data set where OSKM bound together and eight sites
where OSK bound together, but not with c-Myc (Figure S5).
Strikingly, we detected minimal or background signals of
c-Myc at the OSKM ‘‘together’’ target sites in the absence
of OSK and detected nearly a 40-fold increase in binding of
c-Myc in the presence of OSK (Figures 3B and S5B). No c-Myc
binding was observed at OSK ‘‘only’’ sites with or without OSK
(Figures 3B and S5B), and OSK did not enhance c-Myc binding
to sites at which c-Myc binds by itself (data not shown). We
conclude that OSK together act as pioneer factors, directly
enabling c-Myc binding at 48 hr.
We also found that c-Myc enhanced, by more than 2-fold
(p < 0.001–0.0001), the occupancy of O, S, and K to the OSKM
‘‘together’’ sites while having no effect on the occupancy of
O, S, and K to OSK ‘‘only’’ sites (Figures 3C and S5B), indicating
cooperative binding of c-Myc with OSK. We used the Motif
Alignment and Search Tool (MAST) algorithm (Bailey and Grib-
skov, 1998) on our ChIP-seq data set to quantify the enrichment
of the canonical E-box (Myc:Max) motif, the de novo motif we
discovered in early reprogramming for c-Myc (Figure 1B), and
the canonical motifs for O, S, and K. By allowing one mismatchCell 151, 994–1004, November 21, 2012 ª2012 Elsevier Inc. 997
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Figure 4. Oct4, Sox2, and Klf4 Initially
Access Closed Chromatin Extensively
(A) For each of the 188,595 O, S, K, and/or
M-bound sites at 48 hr (average peak width
208 bp), DNaseI sensitivity is displayed in pre-
infected fibroblasts, and the sites are rank ordered
by degree of hypersensitivity (top cyan panel), with
the DNaseI peaks occurrence shown in the second
cyan panel. A red line separates the hypersensitive
from the resistant regions. The top four green
panels show read counts for O, S, K, and/or M
within the bound sites at 48 hr, followed by read
counts of ChIP-seq of designated histone modifi-
cations in uninfected fibroblasts (Lister et al., 2011).
All read counts were input and length normalized
and shown per million mapped tags. Genes at the
top are relevant to reprogramming, validated for
OSKM binding at 48 hr (Table S2), and reside in
DNase-resistant chromatin. Spikes in the DNase-
resistant regions for O, S, K, and M are where the
factors bind strongly together.
(B) As in (A), but for the 156,401 sites where O, S, K,
or M each bind alone at 48 hr.
(C) The three-dimensional structures of the DNA-
binding domains (blue) of FoxA, Oct-Sox2 (PDB-
1GT0), Klf4 (PDB-2WBU), and cMyc (PDB-1NKP) in
complex with their specific respective DNA sites
(red). Free DNA surfaces are indicated, showing
that OSK, but not M, could potentially bind DNA
sites simultaneously with other proteins.for each consensus (p < 10 3 104), we found Oct4, Sox2, Klf4,
and de novo c-Myc motifs, but not the E-box motif, to be
overrepresented in OSKM cobound regions compared to
random DNA of similar sizes (Figure 3D, black bars; red dotted
line indicates random DNA threshold). Whereas Oct4, Sox2,
and Klf4 binding motifs were equally enriched in OSK- versus
OSKM-bound regions, the de novo c-Mycmotif was underrepre-
sented in OSK regions (Figure 3D, compare black to gray bars,
p < 0.0001). In conclusion, while the OSK factors allow c-Myc
to access the OSKM sites, c-Myc also cooperatively enhances
the initial OSK engagement with chromatin, driven in part by
a variant c-Myc binding motif.
Oct4, Sox2, and Klf4 Bind as Pioneer Factors to Closed
Chromatin
To further assess the pioneer activity of the pluripotency factors,
we determined where they bound at 48 hr with regard to pre-ex-
isting DNaseI hypersensitive sites by using human BJ fibroblast
data from the UW ENCODE project (Myers et al., 2011). Remark-998 Cell 151, 994–1004, November 21, 2012 ª2012 Elsevier Inc.ably,we found that themajority (70%,n=
127,059) of all Oct4, Sox2, Klf4, and, to
a much lesser extent, c-Myc initial binding
events at 48 hr occur in DNaseI-resistant
regions, representing closed chromatin
(Figure 4A). Only 32% of OSKM binding
events (n = 61,536) occurred at pre-
existing DNase-sensitive regions, mostly
by c-Myc, Klf4, and Oct4. Within the
DNaseI-resistant regions, sites that aremost enriched for Oct4, Klf4, and c-Myc are cobound bymultiple
factors (Figure 4, ‘‘spikes’’ in ChIP-seq signals). Notably, many of
the genes bound that promote reprogramming reside in the
DNaseI-resistant portion of the genome (Figure 4A, top).
In assessing where the factors each bind alone at 48 hr, it is
clear that c-Myc alone binds strictly to open chromatin regions,
whereas Oct4, Sox2, and Klf4 each bind extensively, alone, to
closed chromatin (Figure 4B). We note that these findings are
consistent with the ability of O, S, and K, but not M, to bind on
one side of the DNA helix (Nair and Burley, 2003; Reme´nyi
et al., 2003; Schuetz et al., 2011), leaving the other side of
DNA potentially bound to histone octamers or other chromatin
complexes, as seen for FoxA (Cirillo et al., 1998; Clark et al.,
1993) (Figure 4C).
Most Initial Oct4, Sox2, and Klf4 Binding Sites Lack an
Evident Histone Mark
We counted the ChIP-seq reads in uninfected human fibroblasts
for pre-existing histone modifications (Lister et al., 2011) within
Figure 5. OSKM Are Not Strongly Directed
by Pre-existing Histone Modifications
(A) The enrichment of the pre-existing histone
modifications within the OSKM-bound regions
at 48 hr is displayed as a heatmap correlation.
The counts of histone modifications ChIP-seq
reads under each O, S, K, and/or M-bound region
were input and length normalized and expressed
as reads per million mapped tags. The color
display ranges from +10 reads per million (red)
to 10 reads per million (green). Red outlined
regions denote marked correlations.
(B) Left: DNaseI hypersensitivity within regions
cobound by c-Myc alone, and Klf4 and c-Myc
(KM) were divided into groups based on their
distance to TSS (distal, more than 1 kb away from
TSS; proximal, within 1 kb of TSS) and assessed
for DNaseI hypersensitivity, as shown in box and
whisker plots on a log10 scale. The bottom and top
of the box are the 25th and 75th percentiles, and
the middle band is the 50th percentile DNaseI
hypersensitivity value; whisker ends are the
minimum and maximum values. Right: as in the
left panel but showing all O, S, K, and/or M
combinations at 48 hr. The red dotted line repre-
sents the border between hypersensitive and
resistant sites.
(C) O, S, K, and M binding enrichment at distal
elements of genes that gain the H3K4me2 mark in
48 hr, relative to genes that lose the mark (left).
Enrichment of c-Myc and Klf4 at proximal ele-
ments (promoters) of genes that maintain an
H3K4me2 mark (right). H3K4me2 data of Koche
et al. (2011).
See also Figure S6.each site where O, S, K, and M initially bind, focusing on the
immediate environment of binding events. Put simply, 70%
of the sites where O, S, K, and/or M bound were not enriched
for any histone modification tested (Figures 4A and 5A).
We found that only a minority (15%) of sites, mainly where
c-Myc and Klf4 bind at promoters (Figures 5A and S6), were en-
riched for the open chromatin marks H3K4me2, H3K4me3,
H3K9ac, and H3K27ac. c-Myc alone or in combination with
Klf4 often binds promoters that are hypersensitive to DNaseI,
which is consistent with their enrichment for the open histone
marks (Figure 5B, left). However, c-Myc on its own can only
access distal enhancers within open chromatin, unlike KM
binding to enhancers within closed chromatin (Figure 5B, left).
In virtually all cases, c-Myc binding to closed sites is dependent
upon the pioneer activity of the OSK factors (Figure 5B, right).Cell 151, 994–1004, NAs expected, the subset of sites that
will be bound by O, S, K, and/or M and
that were enriched for the open enhancer
mark H3K4me1 (17% of total sites)
were located at distal elements, includ-
ing functional enhancers (Figure S6B).
OSKM binding to distal locations (50–
500 kb) correlates with genes that gain
the H3K4me2 mark de novo at 48 hr
(Koche et al., 2011), relative to distal loca-tions of genes that lose the mark (Figure 5C, left). The promoters
of active genes in fibroblasts that maintain the H3K4me2 mark
are bound by c-Myc and Klf4 and include genes that change
expression at 48 hr (Figure 5C, right; Figure S6C). In summary,
we find minimal effects of pre-existing open histone modifica-
tions on guiding the initial binding of O, S, K, and M to distal
elements; early chromatin changes occur at genes to which
OSKM bind distally, and Oct4, Sox2, and Klf4 act as pioneer
factors for c-Myc at distal elements and promoters.
Megabase-Scale, H3K9me3-Containing Differentially
Bound Regions Are Refractory to Initial OSKM Binding
To identify impediments to the initial access of OSKM to chro-
matin, we searched for regions in the human genome that lacked
OSKM binding at 48 hr and compared them to OSKM binding inovember 21, 2012 ª2012 Elsevier Inc. 999
Figure 6. Megabase-Sized Domains of the Genome Are Refractory
to the Initial Binding of OSKM
(A) Examples of diminished OSKM ChIP-seq signals within OSKM-DBRs
(black rectangles) at 48 hr after induction (top four tracks) compared to those in
H1-ES (bottom four tracks).
(B) The average read count for O, S, K, and M (blue, red, orange, and green
lines, respectively) within DBRs (red bracket) compared to 2 MB flanking
regions at 48 hr (left) and H1-ES (right). Read count is input subtracted, lane
normalized, and expressed as reads per million mapped reads. Size and
number of OSKM-DBRs at 48 hr versus ES cells are indicated.
(C) Genes are typically silent within OSKM-DBRs and exhibit activation in iPS
and ES cells. Microarray gene expression in hFib, hFib-iPS, and H1-ES is
shown as box and whisker plots along a log2 scale.
See also Figure S7 and Table S4.H1-hES cells (Lister et al., 2009). We identified 264 contiguous
swaths of the fibroblast genome of 2.2 megabase average size
that were refractory to OSKM binding at 48 hr, compared to
that in hES cells, which we call OSKM-DBRs (Figures 6A and
6B). Interestingly, gene ontology reveals late genes that are
required for pluripotency, such as NANOG, DPPA4, SOX2,
GDF3, and PRDM14 (Buganim et al., 2012) within OSKM-
DBRs, along with many others required for cell differentiation
(Table S4). Overall, the DBRs are gene poor by about 2-fold
versus the rest of the genome and are enriched for repeat
elements (Table S4). Whereas the expression of genes outside1000 Cell 151, 994–1004, November 21, 2012 ª2012 Elsevier Inc.OSKM-DBRs is relatively similar between hFib, iPS, and ES cells,
the expression of genes inside them is higher in ES and iPS
compared to hFib cells (Figure 6C) and remains silent after
48 hr of ectopic OSKM expression (Figure S7A). Thus, despite
the pioneer activity of the pluripotency factors at many genomic
sites, large chromatin domains in differentiated cells are refrac-
tory to initial OSKM binding, and the impediment is overcome
during reprogramming.
A recent screen of 21 histone modifiers showed that knocking
down SUV39H1, which elicits H3K9me3 in heterochromatin,
enhances reprogramming markedly (Onder et al., 2012),
but the basis for the effect was not clear. Upon assessing the
ChIP-seq tags of 12 different histonemodifications, we observed
a striking average enrichment for the H3K9me3mark specifically
at OSKM-DBRs in hFib cells, but not in H1-hES cells (Figure 7A).
TheOSKM-DBRs showed no such consistent enrichment for any
other histone mark. H3K9me3 was about 10-fold more enriched,
on average, than H3K9me2 at OSKM-DBRs (Figure S7B); this is
like other studies showing only a partial concurrence of the two
modifications (Chandra et al., 2012; Wen et al., 2009).
Further analysis of the OSKM-DBRs in ‘‘preinfected’’ fibro-
blasts revealed them to be more DNase resistant than flanking
domains and to contain more highly demethylated DNA than
in ES cells (Figure S7C). Strikingly, 75% of the OSKM-DBRs
contain an overlap with lamin-associated domains (LADs) over
50% of the DBR sequence (Table S4), though we note that
LADs are far more prevalent in the genome than the DBRs
(Guelen et al., 2008). In summary, the OSKM-DBRs possess
features of heterochromatin. Interestingly, the OSKM-DBR loca-
tions wemapped in fibroblasts exhibit varying H3K9me3 levels in
different cell types (Figure S7D).
To investigate the role of H3K9me3 at OSKM-DBRs in
fibroblasts, we transiently knocked down the related histone
methyltransferases SUV39H1 and SUV39H2 together, SETDB1
alone, or all three together with a two-stage small interfering
RNA (siRNA) knockdown strategy, compared to a nontargeting
(NT) control siRNA. After 48 hr induction of OSKM in the knock-
down cells, we performed ChIP-qPCR for Oct4 and Sox2 at 18
different sites inside OSKM-DBRs and 12 sites in flanking
regions. Oct4 and Sox2 were significantly more enriched at sites
inside OSKM-DBRs after inducing OSKM for 48 hr in the knock-
down cells, compared to hFib cells treated with the NT siRNA
(p < 0.05) (Figure 7B). Importantly, we observed no difference
in Oct4 and Sox2 enrichment at sites flanking OSKM-DBRs (Fig-
ure 7B). Also, knocking down SUV39H1/H2, which greatly
diminished H3K9me3, allowed more access for Oct4 and Sox2
to DBRs with respect to the SETDB1 knockdown, which ex-
hibited less diminution of H3K9me3 (Figures 7B, S7E, and
S7F). Thus, H3K9me3 impedes the initial access of OSKM to
the DBRs. Overall, knocking down any of the H3K9 methyl-
transferases significantly accelerated the appearance of
newly reprogrammed colonies (Figure 7C). More specifically,
SUV39H1/H2 knockdown significantly enhanced the efficiency
of reprogramming after dox withdrawal, as tested by Tra-1-60
staining (Figure 7C). Thus, H3K9me3 impedes reprogramming
by blocking the initial engagement of OSKM at broad chro-
matin domains, some of which are necessary for promoting
pluripotency.
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Figure 7. H3K9me3 Is Markedly Enriched at
OSKM-DBRs and Is an Impediment to Initial
OSKM Binding
(A) Read counts of ChIP-seq of histone modifica-
tions in uninfected human fibroblasts (left) and
human ES cells (right) (Lister et al., 2011) are
displayed within DBRs (red brackets) compared
to 2 MB flanking regions. Read counts were input
and length normalized and shown per million
mapped tags.
(B) Fibroblasts were treated with either NT siRNA,
SUV39H1/H2 siRNA, or SETDB1 siRNA twice
before being infected with OSKM+rtTA lentivi-
ruses, and OSKM expression was induced for
48 hr with dox (see Figures S7E and S7F). ChIP-
qPCRs for Oct4 and Sox2 were carried out at
18 sites within DBRs and 12 sites flanking each
DBR (Table S2) as controls. Means ±SEM of two
biological replicates; each qPCR reaction with
three technical replicates.
(C) Knockdown of H3K9 histone methyltrans-
ferases increases the speed with which colonies
appear after inducing OSKM with dox (left).
Means ±SEM of three biological replicates.
Knockdown of SUV39H1and SUV39H2 leads to an
increase in Tra-1-60-positive colonies, indicating
enhanced reprogramming (right).
See also Figure S7 and Table S4.DISCUSSION
Most studies of the ability of ectopic transcription factors to
convert cells of one fate to another have largely been phenome-
nological; that is, seeing what works and how cells respond to
the factors. Studies of OSKMbeing able to convert differentiated
cells to pluripotency (Takahashi and Yamanaka, 2006) have
focused on changes in gene expression and histone modifica-
tion at early time points (Koche et al., 2011; Mah et al., 2011)
and chromatin occupancy at the ‘‘pre-iPS’’ stage, well on the
path to conversion (Sridharan et al., 2009). Our analysis reveals
striking differences between the initial binding of the factors
compared to later stages and unanticipated insights about
what needs to be overcome for successful reprogramming.
Notably, ectopically expressed factors extensively engage distal
regulatory elements first; thus, subsequent events are required
for the factors to engage promoters and activate transcription.
O, S, and K act as pioneer factors at closed chromatin sites,
and their binding is not predominantly dictated by pre-existing
histone modifications. c-Myc has a direct function, specified in
part by a variant DNA binding motif, in enhancing the initial chro-Cell 151, 994–1004, Nomatin engagement of O, S, and K. And
despite the pioneer activity of O, S, and
K, we found megabase-sized regions of
the genome that are refractory to OSKM
binding and thereby impede the pace of
reprogramming.
To what extent is the initial binding
pattern in bulk fibroblast cells reflective
of the minority of cells that will success-
fully reprogram? Three points argue thatpositive and negative features observed at 48 hr are informative
in this regard. First, successfully reprogrammed human iPS cells
do not appear for weeks; it is not the case that fully reprog-
rammed cells initially appear and then amplify their numbers
(see Introduction). Many genes required for reprogramming are
not expressed until late in the process, such as Nanog, which
we find to be in a heterochromatic OSKM-DBR and not bound
by OSKM in the first 48 hr. Indeed, we found that H3K9me3 at
DBRs provides an impediment to OSKMbinding and that knock-
ing down enzymes that elicit this mark increases the pace of re-
programming. Further work is needed to understand the steps
by which the OSKM-DBRs in fibroblasts lose H3K9me3 and
allow factor binding in pluripotent cells and the means by which
heterochromatic DBR-like locations that resist reprogramming
may differ across the genomes of different cell types. Along
these lines, we note that 22 of the OSKM-DBRs correspond to
‘‘iPS-DMR’’ regions that fail to lose the H3K9me3 mark and fail
to gain DNA methylation in human iPS cells, as compared to
ES cells (Lister et al., 2011) (Table S4). Thus, a deficiency in con-
verting a small subset of OSKM-DBRs may contribute to differ-
ences between iPS and ES cells.vember 21, 2012 ª2012 Elsevier Inc. 1001
A second point arguing that features of the bulk OSKM
binding pattern at 48 hr are relevant to reprogramming stems
from the binding of OSKM to many genes that are crucial
for the process, including GLIS1, mir-367/302, MET genes,
ARID1B, JARID2, EED, SUZ12, and SALL4 (Table S3). We
find that such binding initially occurs at distal conserved
elements or enhancers (Figures 2C, S4A, and S4B), preceding
marked transcriptional activation (Figures 2A and 2D) but corre-
lating with where H3K4me2 changes occur at associated genes
(Figure 5C). The binding of factors to enhancers first, prior to
binding promoters and gene activity, is reminiscent of early
developmental progenitor cells that are ‘‘marked’’ by pioneer
factor binding at enhancers (Gualdi et al., 1996; Xu et al.,
2009). Along these lines, we found that each of the Oct4,
Sox2, and Klf4 factors on their own could extensively engage
DNaseI-resistant chromatin lacking detectable histone marks
and that the factors could permit c-Myc to gain access to its
target sites where c-Myc could not do so on its own; these
are all features expected of pioneer factors (Zaret and Carroll,
2011). Thus, early events in ectopic factor occupancy at reprog-
ramming gene targets mimic regulatory mechanisms seen in
natural progenitor cell contexts.
A third point arguing that studying early events in the bulk
population is relevant to reprogramming is from insights gained
about c-Myc. c-Myc is not absolutely required for repro-
gramming, yet c-Myc ectopic expression, along with OSK,
dramatically enhances the efficiency and the kinetics of the
early steps of the process, particularly in human cells (see
Introduction). Our work provides an explanation for the early
role of c-Myc. We find that c-Myc facilitates, though is not
absolutely required for, the initial engagement of Oct4, Sox2,
and Klf4 with many chromatin sites, with no indirect effect on
OSK engagement at sites lacking a c-Myc motif and lacking
c-Myc binding (Figures 3C and 3D). Thus, we suggest that
c-Myc has a direct mechanistic role in facilitating the action
of OSK.
A striking difference between the initial OSKMnetwork and the
network seen in pluripotent cells is that, initially, Oct4, Sox2, and
Klf4 bind extensively with c-Myc at distal elements of silent
genes, whereas in pre-iPS and ES cells, c-Myc targets a distinct
network of mainly active genes (see Introduction). Indeed, many
such targets at 48 hr are for genes that promote apoptosis and
senescence (Figures 2B and S3D), which is prominent within
48 hr when c-Myc is used with OSK to reprogram cells (Fig-
ure 3A). Thus, in the bulk population, many ectopic binding
events contribute negatively to reprogramming. We suggest
that the initial binding of ectopic transcription factors to such
genes may serve as a protective mechanism to eliminate
cells in which aberrant transcription factor expression has
occurred, thereby preventing deleterious transdifferentiation
and metaplasia.
In conclusion, the initial binding of OSKM to the fibro-
blast genome has provided diverse insights into the param-
eters that promote and impede the reprogramming process.
By stepwise dissecting the mechanisms of reprogramming,
starting from the initial binding of pioneer-like factors, we
ultimately expect to improve the quality and efficiency of the
process.1002 Cell 151, 994–1004, November 21, 2012 ª2012 Elsevier Inc.EXPERIMENTAL PROCEDURES
Cell Culture
Human foreskin fibroblast cells (BJ) were obtained from the ATCC (CRL-2522)
at passage 6 and cultured in the ATCC-formulated Eagle’s Minimum Essential
Medium supplemented with 10% fetal bovine serum (FBS) at 37C and 5%
CO2. The human H1-ES line (Thomson et al., 1998) and our derived hFib-iPS
cell lines were maintained as described (Lerou et al., 2008). Details on
embryoid body cultures and other procedures below are in the Extended
Experimental Procedures.
Viral Transduction and iPS Generation
We generated iPS cell lines as described (Hockemeyer et al., 2008; Park et al.,
2008). Briefly, BJ cells at passage 10 were infected with lentiviruses encoding
for dox-inducible Oct4, Sox2, Klf4, and c-Myc, along with lentiviruses express-
ing rtTA2M2 in the presence of 4.5 mg/ml polybrene. OSKM factors were
induced by treating the cells with 1 mg/ml dox for 48 hr. The cells were trans-
ferred onto irradiated mouse embryonic fibroblasts (MEFs) and cultured in
human ES media supplemented with 1 mg/ml dox for 28 days. Dox was then
withdrawn, and the cells were cultured for 7 more days, when ES-like colonies
were picked and expanded for ten passages without dox.
Chromatin Immunoprecipitation
Chromatin fragments associated with Oct4, Sox2, Klf4, or c-Myc were
prepared from 107 cells by using 10 mg of antibodies for Oct4 (Abcam
ab19857), Sox2 (R&D AF2018), Klf4 (R&D AF3640), and c-Myc (R&D
AF3696). For ChIP of the OSKM factors in early reprogramming, the chromatin
was obtained from BJ cells infected with OSKM plus rtTA2M2 lentiviruses and
uninfected BJ control cells treated with 1 mg/ml dox for 48 hr, prior to ES
culture. For ChIP of the OSKM factors in ES/iPS cells, the chromatin was
obtained from hFib-iPS cells at passage 15 and human H1-ES cells (Thomson
et al., 1998) at passage 35 that were expanded under feeder-free conditions
for three passages (Ludwig et al., 2006).
Quantitative PCR Analysis
DNA from ChIP was amplified (ABI 7900HT Real-Time PCR System) with
Power SYBR Green qPCR mix (ABI 4367659) as follows: 50C for 4 min and
95C for 10 min and then 45 cycles of 95C for 15 s, 54C for 15 s, and
72C for 45 s. Gene targets and oligonucleotides are in Table S2. PCR spec-
ificity for each primer pair was measured by gel electrophoresis and melting
curve analysis. PCR efficiency for each primer pair was set between 90%
and 100% by generating a standard curve from a 5 log dilution range of input
DNA (slope of3.2 and R2 > 0.98). Threshold cycle values (Ct) used in our anal-
ysis were from three PCR replicates (SD % 0.15) and fit within the ±8%
dynamic range of the standard curve. The enrichment of ChIP DNA over input
DNA was calculated by enrichment = 2(CtChIP DNA Ctinput DNA).
Identification of OSKM Binding Sites and Computational Analysis
OSKMDNA libraries were sequenced by using an Illumina GA2 Sequencer and
aligned to the human genome (NCBI v36 assembly) by using ELAND (default
parameters). Nonunique sequence tags were removed from consideration.
The remaining tags were used to call peaks with MACS (MFOLD = 16) and
were controlled for a FDR of 0.005 (0.5%). Computational analyses were
performed as described by references in the text and in the Extended Exper-
imental Procedures.
ACCESSION NUMBERS
The GEO repository accession number for the ChIP-sequenced tags, peak
assignments, and DBR locations reported in this paper is GSE36570.
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Supplemental Information includes Extended Experimental Procedures, seven
figures, and six tables and can be found with this article online at http://dx.doi.
org/10.1016/j.cell.2012.09.045.
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